Top Markets
#1 Islamic Coin Islamic Coin +152.23%
#2 Bitway Bitway +48.15%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +38.47%
#4 Starpower Starpower +34.30%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.46%
#6 Pons Pons +21.04%
#7 aelf aelf +19.67%
#8 Pleasing Gold Pleasing Gold +17.80%
#9 Venom Venom +14.89%
#10 Decred Decred +14.18%
Coin of the day
Islamic Coin Islamic Coin
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Argenica Therapeutics Ltd Argenica Therapeutics Ltd

Argenica Therapeutics Ltd

AGN
Kedudukan dalam Saham #29930
Argenica Therapeutics Limited, a biotechnology company, engages in the research... Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury. The company was incorporated in 2019 and is based in Nedlands, Australia.
Harga Saham
$0.14810981
Modal Pasaran
$19.03M
Perubahan (1 hari)
2.44%
Perubahan (1 tahun)
-67.22%
Negara
AU
Perdagangan Argenica Therapeutics Ltd (AGN)

Kategori

Healthcare
Sejarah pecahan saham untuk Argenica Therapeutics Ltd (AGN)
Saham Argenica Therapeutics Ltd (simbol: AGN) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 19, 2026.
Satu saham AGN yang dibeli sebelum Aug 19, 2026 kini bersamaan dengan 0 saham AGN.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR